109
Views
34
CrossRef citations to date
0
Altmetric
Original Article

Cannabinoids in glaucoma II: The effect of different cannabinoids on intraocular pressure of the rabbit

, , &
Pages 841-850 | Received 19 Dec 1983, Accepted 20 Mar 1984, Published online: 02 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Natalya M. Kogan & Raphael Mechoulam. (2007) Cannabinoids in health and disease. Dialogues in Clinical Neuroscience 9:4, pages 413-430.
Read now
David W. Pate, Kristiina Järvinen, Arto Urtti, Pekka Jarho & Tomi Järvinen. (1995) Ophthalmic arachidonylethanolamide decreases intraocular pressure in normotensive rabbits. Current Eye Research 14:9, pages 791-797.
Read now
Keith Green & F. McDonald Thomas. (1987) Ocular toxicology of marijuana: an update. Journal of Toxicology: Cutaneous and Ocular Toxicology 6:4, pages 309-334.
Read now

Articles from other publishers (31)

Jared S. Wood, William H. Gordon, Jeremy B. Morgan & R. Thomas Williamson. (2023) Cannabicitran: Its unexpected racemic nature and potential origins. Chirality 35:9, pages 540-548.
Crossref
Daniel J. Nasrallah & Neil K. Garg. (2023) Studies Pertaining to the Emerging Cannabinoid Hexahydrocannabinol (HHC). ACS Chemical Biology.
Crossref
István Ujváry. (2023) Hexahydrocannabinol and closely related semi‐synthetic cannabinoids: A comprehensive review. Drug Testing and Analysis.
Crossref
Cassidy R. LoParco, Matthew E. Rossheim, Scott T. Walters, Zhengyang Zhou, Sofia Olsson & Steve Y. Sussman. (2023) Delta‐8 tetrahydrocannabinol: a scoping review and commentary. Addiction 118:6, pages 1011-1028.
Crossref
Sofia M. Saraiva, Lucía Martín-Banderas & Matilde Durán-Lobato. (2023) Cannabinoid-Based Ocular Therapies and Formulations. Pharmaceutics 15:4, pages 1077.
Crossref
Samir Senapati, Ahmed Adel Ali Youssef, Corinne Sweeney, Chuntian Cai, Narendar Dudhipala & Soumyajit Majumdar. (2022) Cannabidiol Loaded Topical Ophthalmic Nanoemulsion Lowers Intraocular Pressure in Normotensive Dutch-Belted Rabbits. Pharmaceutics 14:12, pages 2585.
Crossref
Diego Caprioglio, Hawraz Ibrahim M. Amin, Orazio Taglialatela-Scafati, Eduardo Muñoz & Giovanni Appendino. (2022) Minor Phytocannabinoids: A Misleading Name but a Promising Opportunity for Biomedical Research. Biomolecules 12:8, pages 1084.
Crossref
Gia-Nam Nguyen, Erin Noel Jordan & Oliver Kayser. (2022) Synthetic Strategies for Rare Cannabinoids Derived from Cannabis sativa . Journal of Natural Products 85:6, pages 1555-1568.
Crossref
Adam M. GilmoreMostafa A. ElhendawyMohamed M. RadwanLinda H. Kidder, Amira S. WanasMurrell GodfreyJana B. HildrethA. Edward RobinsonMahmoud A. ElSohly. (2022) Absorbance-Transmittance Excitation Emission Matrix Method for Quantification of Major Cannabinoids and Corresponding Acids: A Rapid Alternative to Chromatography for Rapid Chemotype Discrimination of Cannabis sativa Varieties . Cannabis and Cannabinoid Research.
Crossref
Leslie Rebibo, Marina Frušić-Zlotkin, Ron Ofri, Taher Nassar & Simon Benita. (2022) The dose-dependent effect of a stabilized cannabidiol nanoemulsion on ocular surface inflammation and intraocular pressure. International Journal of Pharmaceutics 617, pages 121627.
Crossref
Rafael Franco, Rafael Rivas-Santisteban, Irene Reyes-Resina, Mireia Casanovas, Catalina Pérez-Olives, Carlos Ferreiro-Vera, Gemma Navarro, Verónica Sánchez de Medina & Xavier Nadal. (2020) Pharmacological potential of varinic-, minor-, and acidic phytocannabinoids. Pharmacological Research 158, pages 104801.
Crossref
Sally Miller, Laura Daily, Emma Leishman, Heather Bradshaw & Alex Straiker. (2018) Δ 9 -Tetrahydrocannabinol and Cannabidiol Differentially Regulate Intraocular Pressure . Investigative Opthalmology & Visual Science 59:15, pages 5904.
Crossref
Nagendra S. Punyamurthula, Goutham R. Adelli, Waseem Gul, Michael A. Repka, Mahmoud A. ElSohly & Soumyajit Majumdar. (2016) Ocular Disposition of ∆8-Tetrahydrocannabinol from Various Topical Ophthalmic Formulations. AAPS PharmSciTech 18:6, pages 1936-1945.
Crossref
Mei Wang, Yan-Hong Wang, Bharathi Avula, Mohamed M. Radwan, Amira S. Wanas, Zlatko Mehmedic, John van Antwerp, Mahmoud A. ElSohly & Ikhlas A. Khan. (2017) Quantitative Determination of Cannabinoids in Cannabis and Cannabis Products Using Ultra-High-Performance Supercritical Fluid Chromatography and Diode Array/Mass Spectrometric Detection. Journal of Forensic Sciences 62:3, pages 602-611.
Crossref
István UjváryLumír Hanuš. (2016) Human Metabolites of Cannabidiol: A Review on Their Formation, Biological Activity, and Relevance in Therapy. Cannabis and Cannabinoid Research 1:1, pages 90-101.
Crossref
Moritz Schubert & Siegfried R. Waldvogel. (2016) Mo V Reagents in Organic Synthesis . European Journal of Organic Chemistry 2016:11, pages 1921-1936.
Crossref
Moritz Schubert, Kathrin Wehming, Anton Kehl, Martin Nieger, Gregor Schnakenburg, Roland Fröhlich, Dieter Schollmeyer & Siegfried R. Waldvogel. (2016) Molybdenum Pentachloride Mediated Synthesis of Spirocyclic Compounds by Intramolecular Oxidative Coupling. European Journal of Organic Chemistry 2016:1, pages 60-63.
Crossref
Kristin M. Fischer, Daniel A. Ward & Diane V. H. Hendrix. (2013) Effects of a topically applied 2% delta-9-tetrahydrocannabinol ophthalmic solution on intraocular pressure and aqueous humor flow rate in clinically normal dogs. American Journal of Veterinary Research 74:2, pages 275-280.
Crossref
Ketan Hippalgaonkar, Waseem Gul, Mahmoud A. ElSohly, Michael A. Repka & Soumyajit Majumdar. (2011) Enhanced Solubility, Stability, and Transcorneal Permeability of Delta-8-Tetrahydrocannabinol in the Presence of Cyclodextrins. AAPS PharmSciTech 12:2, pages 723-731.
Crossref
Pál Pacher, Sándor Bátkai & George Kunos. (2006) The Endocannabinoid System as an Emerging Target of Pharmacotherapy. Pharmacological Reviews 58:3, pages 389-462.
Crossref
Billy R. Martin, Jenny L. Wiley, Irina Beletskaya, Laura J. Sim-Selley, Forrest L. Smith, William L. Dewey, Jean Cottney, Julia Adams, James Baker, David Hill, Bijali Saha, John Zerkowski, Anu Mahadevan & Raj K. Razdan. (2006) Pharmacological Characterization of Novel Water-Soluble Cannabinoids. Journal of Pharmacology and Experimental Therapeutics 318:3, pages 1230-1239.
Crossref
Tomi Järvinen, David W Pate & Krista Laine. (2002) Cannabinoids in the treatment of glaucoma. Pharmacology & Therapeutics 95:2, pages 203-220.
Crossref
Manfred Braun, Brigitte Meyer & Boris Féaux de Lacroix. (2002) Synthesis of (R)- and (S)-O-Methylcannabispirenone by Desymmetrization ofO-Methylcannabispirone. European Journal of Organic Chemistry 2002:8, pages 1424-1428.
Crossref
Anna Porcella, Chiara Maxia, Gian Luigi Gessa & Luca Pani. (2001) The synthetic cannabinoid WIN55212-2 decreases the intraocular pressure in human glaucoma resistant to conventional therapies. European Journal of Neuroscience 13:2, pages 409-412.
Crossref
Keith Green. 1999. Marihuana and Medicine. Marihuana and Medicine 581 589 .
Larry A. Walker, Ernest C. Harland, Allyson M. Best & Mahmoud A. ElSohly. 1999. Marihuana and Medicine. Marihuana and Medicine 123 135 .
David W. Pate, Kristiina Järvinen, Arto Urtti, Pekka Jarhol, Mette Fich, Vaidyanath Mahadevan & Tomi Järvinen. (1996) Effects of topical anandamides on intraocular pressure in normotensive rabbits. Life Sciences 58:21, pages 1849-1860.
Crossref
Michael F. Sugrue. (1989) The pharmacology of antiglaucoma drugs. Pharmacology & Therapeutics 43:1, pages 91-138.
Crossref
BRENDA K. COLASANTI. (1986) Ocular Hypotensive Effect of Marihuana Cannabinoids: Correlate of Central Action or Separate Phenomenon?. Journal of Ocular Pharmacology and Therapeutics 2:3, pages 295-304.
Crossref
BRENDA K. COLASANTI. (1985) Intraocular Pressure, Ocular Toxicity and Neurotoxicity in Response to 11-Hydroxy-Δ 9 -Tetrahydrocannabinol and 1-Nantradol . Journal of Ocular Pharmacology and Therapeutics 1:2, pages 123-135.
Crossref
Michael F. Sugrue & Robert L. Smith. 1985. 83 91 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.